Melanoma vaccines: The problems of local immunosuppression

Novel strategies for improved cancer vaccines

Conditioning vaccination site with irradiated MIP-3alpha-transfected tumor cells enhances efficacy of dendritic cell-based cancer vaccine

Antitumor vaccines, immunotherapy and the immunological constant of rejection